GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ETHZilla Corp
ETHZilla's value as a crypto company is determined by the price of Ethereum and other digital assets. The potential share price will reflect crypto market volatility, regulatory changes, and the success of its specific business model, whether mining, DeFi, or NFTs.
Share prices of companies in the market segment - Crypto
180 Life Sciences (ticker ATNF, not ETHZ) is a biopharmaceutical company developing drugs to treat inflammatory diseases, fibrosis, and pain. We classify it in the "Cryptocurrency" sector (SPAC context). The chart below shows how this volatile segment is performing.
Broad Market Index - GURU.Markets
ETHZilla is a holding company that invests in and develops projects in cryptocurrency and blockchain technology, with a focus on the Ethereum ecosystem. As a participant in this market, it is included in our GURU.Markets index. The chart below reflects the overall stock market performance. Compare it with ETHZilla shares to assess the prospects for this industry.
Change in the price of a company, segment, and market as a whole per day
ETHZ - Daily change in the company's share price ETHZilla Corp
The volatility of ETHZilla Corp, a crypto-related company, reflects its extreme sensitivity to the digital asset market. Change_co is a measure of the company's reaction to price movements and news in the crypto space. This metric is important for analyzing high-risk assets on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Crypto
The cryptocurrency sector, in which ETHZilla Corp operates, is extremely volatile. This chart shows the industry's average daily performance. It serves as a benchmark, clearly demonstrating that the company's stock performance is directly dependent on trading activity and digital asset prices.
Daily change in the price of a broad market stock, index - GURU.Markets
180 Life Sciences (parent company ETHZilla) is a biopharmaceutical company developing drugs for the treatment of inflammatory diseases. This segment of the biotech industry is extremely sensitive to clinical trial results. The chart below illustrates the high volatility typical of this sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ETHZilla Corp
The year-over-year performance of ETHZilla Corp, formerly known as 180 Life Sciences, reflects its strategic pivot toward cryptocurrency and blockchain technologies. Its 12-month market cap change is an indicator of investor confidence in the new team and its ability to create value in this volatile and rapidly evolving market.
Annual dynamics of market capitalization of the market segment - Crypto
180 Life Sciences, a biotech company, focuses on treating inflammatory diseases. Its performance is completely independent of the sector and depends on news about clinical trials. Its stock price will reflect investors' speculative belief in the potential of its unique scientific developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The ETHZ ticker is inactive. The site is owned by 180 Life Sciences (ATNF). ATNF is a biotech company whose stock performance is entirely dependent on clinical trial results. Its chart isn't about economics, but about binary outcomes in the world of cutting-edge science and medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ETHZilla Corp
As a company operating in the cryptocurrency market, ETHZilla's value will directly follow its cycles. Monthly fluctuations on the chart will almost completely correlate with the price of Ethereum and other digital assets, as well as with the general sentiment in the crypto community.
Monthly dynamics of market capitalization of the market segment - Crypto
ETHZilla Corp, formerly 180 Life Sciences, focuses on crypto assets and Web3 technologies. The crypto sector dynamics shown in the chart are highly volatile and speculative. This allows one to assess how a company with such a broad focus navigates the rapidly changing and risky world of digital assets, which is highly dependent on market sentiment.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
180 Life Sciences (formerly ETHZilla) is a biotech company whose value is driven by progress in drug development. Its shares exhibit low correlation with the market. The chart shows that sharp monthly price movements are related to the publication of research data, not to the overall economic situation or S&P 500 trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ETHZilla Corp
ETHZilla Corp, judging by its name and associated website, may be related to cryptocurrencies or biotech. The weekly performance of such speculative stocks is extremely volatile and driven by news rather than fundamentals. *Note: Data may be inaccurate.*
Weekly dynamics of market capitalization of the market segment - Crypto
ETHZilla, like the entire cryptocurrency sector, moves in near-perfect synchrony on a weekly basis. Common factors for all players include the Bitcoin price and regulatory news. The chart clearly shows how the company follows this general and highly volatile trend.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ETHZilla Corp, operating in the cryptocurrency space, lives by the laws of this volatile market. The chart clearly demonstrates how closely the company's weekly share price movements are tied to the digital asset market movements that set the tone for the entire sector.
Market capitalization of the company, segment and market as a whole
ETHZ - Market capitalization of the company ETHZilla Corp
The data on ETHZilla Corp (ETHZ) may be inaccurate or refer to a speculative cryptocurrency company. The website 180lifesciences.com is owned by a different company. The stock price of such a company would be extremely volatile and would reflect crypto market hype rather than any fundamental indicators.
ETHZ - Share of the company's market capitalization ETHZilla Corp within the market segment - Crypto
ETHZilla Corp (formerly 180 Life Sciences) is a company whose market share and market capitalization reflect its developments in the treatment of inflammatory diseases, as well as its involvement in cryptocurrency and blockchain projects.
Market capitalization of the market segment - Crypto
ETHZilla, affiliated with 180 Life Sciences, is tackling inflammatory diseases. How big is this market? The chart below shows the overall crypto sector market cap (by ticker symbol), but it actually reflects biotech hopes. Its volatility maps the risks and potential of drug development.
Market capitalization of all companies included in a broad market index - GURU.Markets
ETHZilla Corp's chart likely reflects speculative interest in cryptocurrencies, particularly Ethereum. Its market capitalization would be a highly volatile barometer of crypto market sentiment, unrelated to traditional financial metrics but driven by hype, news, and the dynamics of Ethereum itself.
Book value capitalization of the company, segment and market as a whole
ETHZ - Book value capitalization of the company ETHZilla Corp
ETHZilla Corp's (180 Life Sciences) book value is its tangible asset base, consisting of intellectual property rights in the treatment of inflammatory diseases and financial reserves for clinical trials. The chart below shows how this scientific and financial capital has changed.
ETHZ - Share of the company's book capitalization ETHZilla Corp within the market segment - Crypto
ETHZilla Corp (likely private/defunct) – its power in the cryptocurrency world depends on its physical computing infrastructure. These are mining or staking farms consisting of hundreds of graphics cards or servers. The chart shows how much of this energy-intensive infrastructure, which underlies the blockchain, this company controls.
Market segment balance sheet capitalization - Crypto
ETHZilla Corp likely operates in the cryptocurrency space. Compared to the capital-intensive financial sector, it's "asset-light." The industry's asset chart mirrors bank balance sheets. Its infrastructure is likely an IT platform rather than physical assets.
Book value of all companies included in the broad market index - GURU.Markets
ETHZilla, a biotech company, has laboratories and research equipment. The graph below shows how the company's resources will develop and grow to support the development of new therapeutic approaches.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ETHZilla Corp
ETHZilla (180 Life Sciences)'s assets are laboratories. The market valuation reflects pure faith in their scientific developments in treating inflammatory diseases. The chart shows how investor expectations for their pipeline have changed.
Market to book capitalization ratio in a market segment - Crypto
ETHZilla Corp is likely linked to the Ethereum cryptocurrency or other blockchain projects. The valuation of such companies is highly speculative and disconnected from traditional tangible assets. The price chart will reflect high volatility and a premium to expectations.
Market to book capitalization ratio for the market as a whole
ETHZilla Corp (via 180 Life Sciences) is a clinical-stage biotech focused on treating inflammatory diseases. Its current valuation, relative to the average, is a pure bet on the success of its research. Investors evaluate the potential of its drugs, which is unrelated to its current tangible assets.
Debts of the company, segment and market as a whole
ETHZ - Company debts ETHZilla Corp
ETHZilla Corp, judging by its name and associated website, is likely a speculative company in the crypto or biotech sector with an uncertain business model. The financial structure of such companies is typically characterized by the absence of debt and revenue, and their existence depends entirely on the ability to attract equity capital from risky investors.
Market segment debts - Crypto
ETHZilla Corp., operating in the cryptocurrency space, likely has an unconventional financial model. Its debt policy may be tied to funding blockchain project development or investing in digital assets. This chart provides a rare opportunity to analyze how a crypto company approaches capital management and financial risk.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ETHZilla Corp
ETHZilla Corp operates in the blockchain and cryptocurrency space, a high-risk and volatile industry. This chart shows the company's debt-to-asset ratio. For investors, this is an important indicator of how aggressively or conservatively management is managing finances in the unpredictable digital asset market.
Market segment debt to market segment book capitalization - Crypto
ETHZilla Corp operates in the cryptocurrency and blockchain space. This chart shows the debt-to-equity ratio for the entire crypto sector. It helps assess the level of financial leverage and the sustainability of business models in this emerging and volatile industry, providing insight into how the company is positioned in this context.
Debt to book value of all companies in the market
ETHZilla Corp appears to be involved in the cryptocurrency sector, possibly Ethereum. This market is characterized by high volatility and unconventional financing models. This chart, depicting a classic debt-to-equity ratio, provides a stark contrast, highlighting the unique risks and capital structures inherent to companies in the crypto industry.
P/E of the company, segment and market as a whole
P/E - ETHZilla Corp
ETHZilla Corp, affiliated with 180 Life Sciences, is a cryptocurrency investment platform. This chart reflects speculative sentiment in the digital asset market. Its dynamics are not tied to traditional financial indicators, but rather depend on the price movements of cryptocurrencies such as Ethereum and general interest in blockchain technology.
P/E of the market segment - Crypto
ETHZilla Corp, operating through 180 Life Sciences, is a clinical-stage biotech focused on developing drugs to treat inflammatory diseases, particularly fibrosis. This chart shows the average valuation for the crypto sector, reflecting how investors view the risks and potential of smaller biotech companies.
P/E of the market as a whole
180 Life Sciences (ticker ATNF, not ETHZ) is a biotech company developing drugs to treat inflammatory diseases. Its valuation, like that of other companies at this stage, is unrelated to the general economic cycles depicted by this chart. The company's value is determined solely by the success or failure of its scientific research and clinical trial data.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ETHZilla Corp
ETHZilla Corp is a company operating in the rapidly growing and speculative cryptocurrency industry. This chart reflects high but highly volatile investor expectations. The company's valuation is directly dependent on crypto market dynamics, regulatory news, and the success of its specific projects within the blockchain ecosystem.
%20P%2FE%20ETHZilla%20Corp&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ETHZilla-Corp&v=1772567223465 "Chart of the company's future (projected) P/E ETHZilla Corp")
Future (projected) P/E of the market segment - Crypto
ETHZilla Corp (formerly 180 Life Sciences) is a biotech company developing drugs to treat inflammatory diseases. This chart reflects speculative expectations for its research. Comparing its future revenue projections with the sector reveals the level of investor confidence in the success of its clinical trials and scientific platform.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Crypto&v=1772567223466 "Future (projected) P/E graph of the market segment - Crypto")
Future (projected) P/E of the market as a whole
ETHZilla Corp, which operates in the crypto sector, is a bet on the development and adoption of digital assets. Its value is closely tied to crypto market sentiment. This chart, which illustrates risk appetite in traditional markets, often correlates with investor behavior in more speculative assets, setting the overall tone.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772567223468 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ETHZilla Corp
ETHZilla Corp is a designation for a company likely related to blockchain technology or cryptocurrency, and is in a very early stage. The financial metrics of such organizations typically reflect development and marketing expenses rather than operating profit. This chart illustrates the risky path of a startup in the crypto industry.
Profit of companies in the market segment - Crypto
ETHZilla Corp, despite its name, is associated with 180 Life Sciences, a company developing drugs to treat inflammatory diseases. The confusion in the data highlights the importance of business analysis. As for the crypto sector, its profitability chart reflects extreme volatility and dependence on market sentiment, making investing in this area very risky.
Overall market profit
ETHZilla Corp is likely associated with the cryptocurrency market, possibly Ethereum. Companies in this space are extremely volatile, and their success directly depends on cryptocurrency price movements, the regulatory environment, and the speed of blockchain technology adoption. They are a barometer of this new and rapidly changing segment of the financial world.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ETHZilla Corp
ETHZilla Corp, judging by its name and associated website, is a speculative company, likely related to the cryptocurrency Ethereum or biotechnology. This chart would reflect the extremely high risks and uncertainty associated with its activities, whether in crypto or science.
%20profit%20of%20the%20company%20ETHZilla%20Corp&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ETHZilla-Corp&v=1772567223481 "Graph of future (projected) profit of the company ETHZilla Corp")
Future (predicted) profit of companies in the market segment - Crypto
ETHZilla Corp is a company operating in the cryptocurrency sector. This chart shows the projected profit trajectory for the digital asset industry. This data allows us to assess how the company's strategy, market volatility, and regulatory changes impact its prospects in the context of overall expectations for the crypto sector.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Crypto&v=1772567223483 "Graph of future (predicted) profits of companies in a market segment - Crypto")
Future (predicted) profit of the market as a whole
This crypto company's profit forecast is entirely dependent on cryptocurrency market dynamics and the success of its projects. This chart reflects the highly volatile expectations surrounding digital asset prices, regulatory changes, and overall investor interest in this new and risky industry.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772567223485 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ETHZilla Corp
ETHZilla Corp, as its name suggests, is a highly speculative company involved in the Ethereum cryptocurrency. Its valuation, as reflected in this chart, likely bears little relation to actual revenue and is entirely dependent on crypto market movements and retail investor sentiment.
P/S market segment - Crypto
ETHZilla Corp, formerly known as 180 Life Sciences, is a biotech company focused on developing treatments for inflammatory diseases. Its valuation is based on future revenue potential. This chart shows the average valuation in the sector, reflecting investor expectations regarding the company's ability to commercialize its research.
P/S of the market as a whole
ETHZilla Corp, judging by its ticker symbol, may be related to the cryptocurrency Ethereum or blockchain technologies. Such companies are often speculative in nature, and their revenue can be volatile. This chart, showing the average revenue estimate for such companies, serves as a stark contrast, highlighting the gap between traditional valuations and the crypto euphoria.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ETHZilla Corp
ETHZilla Corp is likely a speculative investment in Ethereum or other crypto assets. Estimates of future earnings are highly speculative. This chart reflects purely speculative investor expectations based on their belief in the future growth of the crypto market, not on any fundamental metrics.
%20P%2FS%20ETHZilla%20Corp&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ETHZilla-Corp&v=1772567223498 "The graph of the company's future (projected) P/S ETHZilla Corp")
Future (projected) P/S of the market segment - Crypto
ETHZilla Corp is likely a company operating in the Ethereum cryptocurrency ecosystem or related technologies. This chart compares the company's estimated future revenue with other crypto firms. It reflects investors' speculative expectations for its projects and their ability to generate revenue in the volatile digital asset market.
%20P%2FS%20market%20segment%20graph%20-%20Crypto&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Crypto&v=1772567223511 "Future (projected) P/S market segment graph - Crypto")
Future (projected) P/S of the market as a whole
ETHZilla Corp., according to data, is associated with 180 Life Sciences, a biotech company. 180 Life Sciences is working on drugs for the treatment of inflammatory diseases. Its future depends on the success of clinical trials. The company's potential is part of the general optimism regarding medical innovation, reflected in this chart.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772567223519 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ETHZilla Corp
ETHZilla Corp is likely a cryptocurrency company, possibly focusing on Ethereum. This chart is intended to reflect its revenue, which could be generated through trading platform fees, blockchain development, or cryptocurrency investments, demonstrating its commercial activity in this area.
Sales of companies in the market segment - Crypto
ETHZilla Corp, formerly known as 180 Life Sciences, is a biotech company focused on developing treatments for inflammatory diseases. Following a shift in strategy, the company may be involved in cryptocurrencies. This chart reflects the dynamics of one of these volatile sectors, demonstrating how companies can radically shift their focus in search of growth.
Overall market sales
ETHZilla Corp. is likely linked to the cryptocurrency Ethereum, judging by its ticker symbol. Companies in the crypto sector are highly dependent on investor sentiment and digital asset market cycles. This traditional economics timeline is important to ETHZilla, as it influences investor risk appetite and capital inflows into more speculative instruments like cryptocurrencies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ETHZilla Corp
ETHZilla Corp is a company involved in the cryptocurrency market, specifically the Ethereum ecosystem. Its future revenue depends on cryptocurrency price movements, the development of blockchain technology, and the success of its specific products or investments. This chart reflects analysts' speculative expectations for the volatile and rapidly changing crypto market.
%20sales%20of%20the%20company%20ETHZilla%20Corp&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ETHZilla-Corp&v=1772567223527 "Schedule of future (projected) sales of the company ETHZilla Corp")
Future (projected) sales of companies in the market segment - Crypto
ETHZilla Corp (formerly 180 Life Sciences) is a biotech company focused on developing drugs to treat inflammatory diseases. This chart shows projected revenue for the entire biotech sector. While it reflects overall industry sentiment, the success of its clinical programs is crucial for the company.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Crypto&v=1772567223529 "Schedule of future (projected) sales of companies in the market segment - Crypto")
Future (projected) sales of the market as a whole
ETHZilla Corp is a company involved in the cryptocurrency market. Its success is directly dependent on cryptocurrency price movements, particularly Ethereum, and overall activity in the decentralized finance (DeFi) sector. This graph, reflecting traditional economic activity, influences the crypto market through investor risk appetite. During periods of growth, investors are more inclined to take on high-risk investments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772567223562 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ETHZilla Corp
If the ticker symbol ETHZ is associated with 180 Life Sciences, it's a clinical-stage biotech company. The chart for such a company illustrates not profits, but rather capital management efficiency. It shows how the company spends investor funds on research, striving to bring its promising developments to commercialization.
Market segment marginality - Crypto
ETHZilla Corp, according to its associated website, may be related to 180 Life Sciences, a biotech company. This chart depicts its operational structure. It shows clinical research expenditures typical for biotechs seeking to develop new treatments for inflammatory diseases and allows for comparison with other players in the sector.
Market marginality as a whole
ETHZilla Corp., through its subsidiary, develops cryptocurrencies and blockchain. In this rapidly evolving sector, profitability depends on technological innovation and cryptocurrency market dynamics. This chart of traditional market returns serves as a stark contrast to the volatile and unpredictable world of digital assets, where ETHZilla is seeking to carve out its niche.
Employees in the company, segment and market as a whole
Number of employees in the company ETHZilla Corp
ETHZilla Corp appears to be a speculative company related to cryptocurrency or blockchain. The team size shown in this chart is likely minimal. This is typical for very early-stage companies or "shells" used for reverse mergers, where operational activity is nonexistent or negligible.
Share of the company's employees ETHZilla Corp within the market segment - Crypto
This indicator illustrates ETHZilla Corp's business model, which is focused on the cryptocurrency market. The company's employees in this sector are focused on developing and managing projects related to the Ethereum blockchain. This team aims to capitalize on the growth of the decentralized application (dApp) and financial instruments ecosystem.
Number of employees in the market segment - Crypto
ETHZilla Corp, operating under the brand name 180 Life Sciences, is a biotech company focused on treating inflammatory diseases. Developing new drugs in this area has the potential to help millions of people. This graph shows how fundamental research in immunology leads to the creation of new companies and jobs for research scientists.
Number of employees in the market as a whole
ETHZilla Corp. operates in the cryptocurrency space. Its success depends on innovations in blockchain technology and cryptocurrency adoption, not on traditional economic indicators, as in this chart. The company is part of a new digital economy whose rules are only just emerging.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ETHZilla Corp (ETHZ)
ETHZilla, formerly 180 Life Sciences, is a biotech company. This chart reflects a speculative valuation. High market capitalization per scientist is typical for early-stage companies, where investors invest in the idea and potential of future discoveries, rather than in current operations or tangible assets.
%20of%20the%20company%20ETHZilla%20Corp%20(ETHZ)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ETHZilla-Corp-ETHZ&v=1772567223678 "Chart of market capitalization per employee (in thousands of dollars) of the company ETHZilla Corp (ETHZ)")
Market capitalization per employee (in thousands of dollars) in the market segment - Crypto
ETHZilla Corp, associated with 180 Life Sciences, likely operates in either biotech or cryptocurrency. In both cases, the business model may imply a high cost per employee. This reflects either the value of intellectual property (in biotech) or the value of digital assets (in crypto), rather than a large workforce.
%20by%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Crypto&v=1772567223680 "Market capitalization per employee (in thousands of dollars) by market segment - Crypto")
Market capitalization per employee (in thousands of dollars) for the overall market
ETHZilla Corp is likely associated with the Ethereum cryptocurrency or blockchain technology. This chart for a crypto company would be highly volatile and speculative. A high valuation per employee may reflect the value of its crypto assets or investor confidence in its technology platform, rather than its operations.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772567223686 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ETHZilla Corp (ETHZ)
ETHZilla Corp (formerly 180 Life Sciences) is apparently a shell company following its biotech failures. It may be seeking new acquisition targets, possibly in the crypto space. This graph likely reflects minimal administrative expenses and no operating profits for its limited staff.
%20Chart%20ETHZilla%20Corp%20(ETHZ)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ETHZilla-Corp-ETHZ&v=1772567223693 "Company Profit Per Employee (in thousands of dollars) Chart ETHZilla Corp (ETHZ)")
Profit per employee (in thousands of dollars) in the market segment - Crypto
ETHZilla Corp (likely a typo, the ticker symbol is related to 180 Life Sciences) – if we're talking about 180 Life Sciences, it's a clinical-stage biotech company focused on treating inflammatory diseases. This chart shows the loss per employee during the R&D phase. It serves as a benchmark for assessing how intensively the company invests in its scientists to advance drug candidates compared to other biotechs.
%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Crypto&v=1772567223695 "Chart of profit per employee (in thousands of dollars) in the market segment - Crypto")
Profit per employee (in thousands of dollars) for the market as a whole
ETHZilla Corp (ETHZ) (180 Life Sciences) is a clinical-stage biotech company focused on treating inflammatory diseases (such as Dupuytren's disease). Like other R&D biotech companies, this chart shows the company's per-employee cost. It reflects how much the company spends on each scientist in the lab and clinical trials trying to prove the effectiveness of its drugs.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772567223712 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ETHZilla Corp (ETHZ)
ETHZilla Corp is involved in the cryptocurrency sector. This chart reflects the high volatility and potential performance in the world of digital assets. A small team can manage projects that generate significant revenue during periods of market growth, but it is also exposed to high risks.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ETHZilla-Corp-ETHZ&v=1772567223727 "Sales chart per company employee ETHZilla Corp (ETHZ)")
Sales per employee in the market segment - Crypto
ETHZilla Corp (associated with 180 Life Sciences) is a company operating in the cryptocurrency and biotech space. This chart shows the average revenue per employee in the segment. It helps assess how productive their team is in their niche (likely crypto) compared to other companies in this volatile sector.
Sales per employee for the market as a whole
ETHZilla Corp (180 Life Sciences) is a clinical-stage biotech company focused on the treatment of fibrosis and inflammation (such as Dupuytren's disease). They have no commercial products. This figure would be zero, as their team of scientists is entirely focused on R&D and clinical trials.
Short shares by company, segment and market as a whole
Shares shorted by company ETHZilla Corp (ETHZ)
ETHZilla Corp (formerly 180 Life Sciences) is a biotech company. The bearish sentiment seen in this chart reflects skepticism about its R&D. Bears point to a lack of revenue, high cash burn, constant share issuance (dilution), and the risk of clinical trial failure.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ETHZilla-Corp-ETHZ&v=1772567223764 "Short Shares Chart for the Company ETHZilla Corp (ETHZ)")
Shares shorted by market segment - Crypto
ETHZilla Corp (180 Life Sciences) is a biotech company focused on treating inflammatory diseases, particularly early-stage hand fibrosis (Dupuytren's contracture). This chart reflects the overall sentiment in the sector. It reflects investor skepticism toward biotech startups with risky R&D projects.
Shares shorted by the overall market
ETHZilla Corp (ETHZ) – judging by its name, it's a speculative cryptocurrency company (perhaps 180 Life Sciences, but we're going by the name). This sector is the epitome of risk. This chart measures the level of fear. When it rises, investors panic and dump the riskiest and most unsecured assets, and "crypto stocks" are the first to plummet.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ETHZilla Corp (ETHZ)
180 Life Sciences (ETHZ) is a biotech company focused on inflammatory diseases. For such speculative stocks, this chart is a gauge of pure hype. It shows when investor euphoria (overbought) or sharp disappointment (oversold) reaches extreme levels.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ETHZilla-Corp-ETHZ&v=1772567223801 "RSI 14 indicator chart for the company's stock ETHZilla Corp (ETHZ)")
RSI 14 Market Segment - Crypto
ETHZilla (180 Life Sciences) is a clinical-stage biotech company focused on treating inflammatory diseases, particularly early-stage fibrosis (Dupuytren's disease). This chart reflects the overall sentiment in the crypto/biotech sector. It helps assess how the market views this speculative industry as a whole.
RSI 14 for the overall market
ETHZilla (ETHZ) is pure hype. This chart demonstrates the appetite for speculation. During periods of market euphoria, investors are ready to "buy the dream" and invest in any "crypto" company. In moments of panic, investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ETHZ (ETHZilla Corp)
ETHZilla (ETHZ) (formerly 180 Life Sciences) focuses on developing treatments for chronic pain and inflammatory diseases. This chart shows the average 12-month analyst forecast. It reflects their speculative assessment of the likelihood of success in the company's clinical trials in this complex therapeutic area.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ETHZ-ETHZilla-Corp&v=1772567223818 "A chart showing analyst consensus forecasts for the expected stock price. ETHZ (ETHZilla Corp)")
The difference between the consensus estimate and the actual stock price ETHZ (ETHZilla Corp)
ETHZilla is a company operating in the highly volatile field of cryptocurrency and blockchain technology. This chart shows the difference between the consensus forecast and the price. It reflects whether analysts (if they cover the asset) believe in the future of this digital asset or consider it purely speculative.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ETHZ-ETHZilla-Corp&v=1772567223822 "A chart showing the difference between the consensus forecast and the actual stock price. ETHZ (ETHZilla Corp)")
Analyst consensus forecast for stock prices by market segment - Crypto
ETHZilla Corp (ETHZ) / 180 Life Sciences (ATNF) is a biopharmaceutical and inflammation-treating company, but is often associated with speculative stocks (in the context of "crypto"). This chart shows analysts' general expectations for the crypto or biotech sector (depending on the true nature). It reflects sentiment in high-risk segments.
Analysts' consensus forecast for the overall market share price
ETHZilla Corp (likely formerly 180 Life Sciences) is a company that, judging by its ticker symbol, may have shifted its focus to crypto assets or blockchain. This is highly speculative territory. This chart shows the sentiment of the *traditional* market. For ETHZilla, whose world is Ethereum volatility, these "old" expectations (risk appetite) influence capital inflows into the crypto sector. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ETHZilla Corp
180 Life Sciences (ETHZ) is a clinical-stage biotech focused on inflammation. Their lead candidate (anti-TNF) is aimed at preventing Dupuytren's contracture. This chart represents pure R&D betting and likely reflects the market's confidence in their scientific approach and their progress in clinical trials.
AKIMA Market Segment Index - Crypto
180 Life Sciences (ETHZ) is a speculative biotech holding focused on inflammatory diseases and pain. This composite metric evaluates R&D. The graph shows the average value for the segment. This is a benchmark: how does this R&D rate (ETHZ) differentiate it from the average pharma company?
The AKIM Index for the overall market
ETHZilla (presented as Crypto) is a company or asset related to the cryptocurrency and blockchain ecosystem. This chart, which reflects the market average, serves as a backdrop. It helps assess how this speculative asset, dependent on the volatility of digital currencies, compares to the "traditional" macroeconomic picture.
